title: Her 2 in 1.
abstract: In this issue of Cancer Cell, Park et al. demonstrate that anti-erbB2 antibody primes adaptive immunity for increased tumor clearance and suggest that chemotherapy may in fact interfere with this process.
authors: Peter MacCallum Cancer Centre, St. Andrews Place, East Melbourne, Victoria, Australia. mark.smyth@petermac.org
authors: Mark J
authors: MJ
authors: Smyth
authors: John
authors: J
authors: Stagg